Traders Lock In ProfitsThe Monday decline represents a natural correction. Retail traders are likely engaging in profit-taking after the historic rally. On Friday, intense buying pressure triggered an upside circuit breaker for the stock.Earnings Beat Wall Street EstimatesThe Friday rally followed the company’s Thursday after-hours earnings report.P3 Health Partners reported a quarterly loss of $1.72 per share. This performance beat the analyst consensus estimate of a $3.28 loss per share. It also marks an improvement from the loss of $6.28 per share reported in the same period last year.Quarterly sales reached $386.390 million, up from $373.225 million year-over-year. However, sales missed the analyst consensus estimate of $391.500 million, according to Benzinga Pro.Analyst Raises Price ForecastDespite the mixed revenue, Lake Street analyst Ben Haynor expressed optimism on Friday. Haynor maintains a buy rating on P3 Health Partners. Notably, he raised the price forecast on the stock from $4 to $14.The company adjusted its fiscal 2026 sales outlook. Management narrowed guidance from the previous $1.500 billion to $1.700 billion range down to $1.500 billion to $1.650 billion. Wall Street’s estimate sits at $1.539 billion.Short Interest Dynamics ShiftRecent data shows a slight decline in short interest. Short positions fell from 74,530 to 72,090 shares. This leaves 18.8% of the company’s public float sold short. Given the average daily volume of 9,500 shares, short sellers require 7.59 days to cover their positions.Critical Levels To Watch for PIII StockThe bigger-picture trend is still pointed up, but the stock is extremely extended versus its moving averages—trading about 145.7% above the 20-day SMA ($3.50) and 65.7% above the 200-day SMA ($5.19).RSI is the key momentum read here, and at 93.56 it’s deep in overbought territory.The moving-average structure is mixed: the 20-day SMA is above the 50-day SMA (bullish near-term trend), but the 50-day SMA remains below the 200-day SMA.